News & Opinionn

 

FDA Says Certain Type 2 Diabetes Drugs Can Cause Serious Joint Pain

 

By Alanna McCatty

August 31, 2015

The U.S. Food and Drug Administration (FDA) said in a safety alert that some widely used treatments for Type 2 diabetes can cause severe and disabling joint pain, raising concerns for a big-selling class of drugs. The FDA alert applies to a category of pills known as DPP-IV inhibitors, which include AstraZeneca PLC’s diabetes drug Onglyza, and Tradjenta. Via The Wall Street Journal. Posted August 28, 2015.

–Alanna McCatty

Average: 0
The following two tabs change content below.
Alanna McCatty

Alanna McCatty

Alanna McCatty is a senior Communications major at Pace University. At MedShadow, she reports on new findings and research on the side effects of prescription drugs.
Alanna McCatty

Latest posts by Alanna McCatty (see all)

     

    Last updated: September 14, 2015